←Back to Expert Scholars
Translational Medicine / 转化医学Neoadjuvant Therapy and ctDNA, Colorectal
Deborah Schrag
MD, MPH
🏢Memorial Sloan Kettering Cancer Center🌐USA
Chair, Department of Medicine
95
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Deborah Schrag led the PROSPECT trial showing that neoadjuvant FOLFOX with selective chemoradiation is non-inferior to chemoradiation for locally advanced rectal cancer. She chairs the Department of Medicine at MSK. Her work has reshaped perioperative rectal cancer strategy and de-escalation.
Share:
🧪Research Fields 研究领域
PROSPECT trial
rectal cancer chemoradiation de-escalation
health services
CRC quality measurement
perioperative strategy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Deborah Schrag 的研究动态
Follow Deborah Schrag's research updates
留下邮箱，当我们发布与 Deborah Schrag（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment